Integrated Transcriptomic and Secretome Proteomic Analysis of Hyperglycemia-Stimulated Endothelial Cells and Screening of Target Compounds
Journal of Visualized Experiments · 2025
DOI: 10.3791/69578 ↗At a glance
Video/Audio in Journal of Visualized Experiments, 2025. Written by Min Shi and 7 co-authors. Institution: Hebei Luoxue Innovation Medicine Research Institute; State Key Laboratory for Innovation and Transformation of Luobing Theory. Major MEDLINE topics: Proteomics, Endothelial Cells, Hyperglycemia, Gene Expression Profiling. 43 references.
Abstract (original language)
Endothelial dysfunction is a key driver of diabetic kidney disease (DKD), but its systemic molecular mechanisms remain incompletely decoded. We hypothesized that integrated multi-omics analysis could map hyperglycemia-induced endothelial damage and identify reusable therapeutics. A reusable computational pipeline was applied to integrate transcriptomic/secretome profiles from hyperglycemic endothelial cells and diabetic kidneys. This identified 534 commonly upregulated genes/proteins. Functional enrichment revealed activation of extracellular matrix remodeling, intercellular communication, and inflammation pathways. Cross-database validation refined 278 high-confidence mediators, and protein-protein interaction network analysis pinpointed ten hub genes. Using network pharmacology, we screened an approved drug library, identifying several candidate compounds (e.g., bruceantin, idelalisib) that potentially target this network. Furthermore, transcription factor regulation and exemplary molecular docking simulations (e.g., idelalisib with CTCF/BRD4) provided mechanistic hypotheses for experimental validation. In conclusion, this study establishes a reusable multi-omics framework that delineates endothelial pathogenic mechanisms in DKD and nominates repurposable drug candidates, offering a strategic approach for mechanistic and therapeutic discovery.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Hebei Luoxue Innovation Medicine Research Institute; State Key Laboratory for Innovation and Transformation of Luobing Theory.
- Hebei University of Chinese Medicine.
- Hebei Medical University.
- Chengde Medical University.
- Hebei Luoxue Innovation Medicine Research Institute; State Key Laboratory for Innovation and Transformation of Luobing Theory; Hebei University of Chinese Medicine; Hebei Medical University; limengnan413@163.com.
Cite
APA
Shi, M., Meng, Y., Hou, B., Kang, T., Tu, H., Li, Y., Li, K., & Li, M. (2025). Integrated Transcriptomic and Secretome Proteomic Analysis of Hyperglycemia-Stimulated Endothelial Cells and Screening of Target Compounds. Journal of Visualized Experiments. https://doi.org/10.3791/69578
Vancouver
Shi M, Meng Y, Hou B, Kang T, Tu H, Li Y, et al. Integrated Transcriptomic and Secretome Proteomic Analysis of Hyperglycemia-Stimulated Endothelial Cells and Screening of Target Compounds. Journal of Visualized Experiments. 2025. doi:10.3791/69578
BibTeX
@article{Shi2025,
author = {Shi, Min and Meng, Yongjie and Hou, Bin and Kang, Tianyu and Tu, Huifang and Li, Yanan and Li, Kaixin and Li, Mengnan},
title = {Integrated Transcriptomic and Secretome Proteomic Analysis of Hyperglycemia-Stimulated Endothelial Cells and Screening of Target Compounds},
journal = {Journal of Visualized Experiments},
year = {2025},
doi = {10.3791/69578}
}
EUVIMED